Tissue-Specific Immunopathology in Fatal COVID-19

Area of Science:

• Immunopathology
• Virology
• Pulmonary Medicine

Background:

• Corticosteroids improve survival in severe COVID-19, indicating a role for immune responses in mortality.
• The precise relationship between SARS-CoV-2 presence and detrimental inflammation in severe disease remains unclear.

Purpose of the Study:

• To investigate SARS-CoV-2 organ distribution and associated inflammatory responses.
• To explore the links between viral presence, inflammation, and organ damage in fatal COVID-19.

Main Methods:

• Postmortem tissue analysis from 11 cases of fatal COVID-19.
• Multiplex PCR, sequencing, and in situ S protein detection for viral mapping.
• Histological quantification of inflammation across 37 sites and multiplex immunofluorescence for pulmonary immune profiling.

Main Results:

• Aberrant immune responses were observed, primarily in the lungs and reticuloendothelial system, often not directly correlated with viral load.
• Inflammation and organ dysfunction did not consistently align with SARS-CoV-2 distribution at tissue or cellular levels.
• Lung findings included monocyte/myeloid-rich arteritis and increased macrophage/monocyte infiltration; lymphoid tissues showed plasmacytosis and iron-laden macrophages, independent of viral presence.

Conclusions:

• Severe COVID-19 exhibits tissue-specific immunopathology, with a substantial virus-independent, immune-mediated component driving severe disease.
• Novel immunopathologic mechanisms are identified, supporting therapeutic strategies targeting macrophage and plasma cell responses.
• Findings support strategies aimed at modulating immune responses and promoting pathogen tolerance in COVID-19 management.